Literature DB >> 11920247

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

B A Van der Reijden1, L de Wit, S van der Poel, E B Luiten, M Lafage-Pochitaloff, N Dastugue, J Gabert, B Löwenberg, J H Jansen.   

Abstract

INTRODUCTION: The chromosome rearrangements inv(16)(p13q22) or t(16;16)(p13;q22) are present in approximately 10% of all cases with de novo acute myeloid leukemia and define a subgroup with a favorable prognosis. Both aberrations result in a CBFB-MYH11 fusion gene that can be detected by RT-PCR. PATIENTS AND METHODS: To date, a total of 10 different in-frame CBFB-MYH11 fusion transcripts have been identified. A newly described transcript can not be amplified with the commonly used PCR primers since the MYH11 junction is located outside the amplified region (MYH11 cDNA position 2134).
RESULTS: We describe here a robust two-step RT-PCR assay that reliably detects all known CBFB-MYH11 transcripts types, including the new variant.
CONCLUSION: Because all previously established RT-PCR protocols may miss the new CBFB-MYH11 transcript, we propose to use the improved RT-PCR approach described here for the reliable detection of all known CBFB-MYH11 fusion transcripts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11920247     DOI: 10.1038/sj.thj.6200103

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  7 in total

1.  RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1).

Authors:  R Katherine Hyde; P Paul Liu
Journal:  J Cell Biochem       Date:  2010-08-01       Impact factor: 4.429

2.  Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

Authors:  Yasuhiko Kamikubo; Ling Zhao; Mark Wunderlich; Takeshi Corpora; R Katherine Hyde; Thomas A Paul; Mondira Kundu; Lisa Garrett; Sheila Compton; Gang Huang; Linda Wolff; Yoshiaki Ito; John Bushweller; James C Mulloy; P Paul Liu
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

3.  Comprehensive analysis of CBFbeta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis.

Authors:  ShriHari S Kadkol; Annette Bruno; Carol Dodge; Valerie Lindgren; Farhad Ravandi
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

4.  [Acute myelomonocytic leukemia eosinophilic revealed by acute pancreatitis].

Authors:  Aziz Touaoussa; Khalid Elhmadi; Hind El Youssi; Hichameddou Moncef; Moncef Amrani Hassani
Journal:  Pan Afr Med J       Date:  2015-02-09

5.  Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.

Authors:  Wenyi Zhang; Hainan Wang; Peilei Zhang; Hongliang Li; Xiaoli Ma; Hongxing Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-29       Impact factor: 2.590

6.  The effect of oligonucleotide microarray data pre-processing on the analysis of patient-cohort studies.

Authors:  Roel G W Verhaak; Frank J T Staal; Peter J M Valk; Bob Lowenberg; Marcel J T Reinders; Dick de Ridder
Journal:  BMC Bioinformatics       Date:  2006-03-02       Impact factor: 3.169

Review 7.  Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.

Authors:  Lisa Richter; Yiqian Wang; R Katherine Hyde
Journal:  Oncotarget       Date:  2016-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.